At the last check on Thursday, HealthEquity Inc.’s (NASDAQ:HQY) stock was up $2.1, moving up 2.96 percent to $73.07. The average number of shares traded per day over the past five days has been 793,658 shares. 5 times new highs have been achieved over the past 5 days, with a $4.12 gain in that time frame. In the last twenty days, the average volume was 630,905, while in the previous 50 days, it was 552,154.
Since last month, HQY stock rose 7.98%. Shares of the company fell to $65.18 on 09/05/23, the lowest level in the past month. A 52-week high of $79.20 was reached on 09/21/23 after having rallying from a 52-week low of $48.86. Since the beginning of this year, HQY’s stock price has risen by 18.54% or $11.08, and marked a new high 13 times. However, the stock has declined by -7.74% since its 52-week high.
HQY stock investors should be aware that HealthEquity Inc. (HQY) stock had its last reported insider trading activity 14 days ago on Sep 07. Murdock Tyson D., the SPECIAL ADVISOR of the company, disposed of 2,844 shares for $71.35 on Sep 07. It resulted in a $202,919 divestment by the insider. Kessler Jon sold 27,230 shares at an average price of $60.96 on Jun 27. The insider now owns 3,875 shares following the transaction. On Jun 26, PRESIDENT AND CEO Kessler Jon sold 19,588 shares at $60.12 apiece. The transaction was valued at $1,177,660.
Valuation Metrics
Right now, HealthEquity Inc. (HQY) has a P/E ratio of about 493.71. The stock’s beta is 0.78. Besides these, the trailing price-to-sales (P/S) ratio of 6.63, the price-to-book (PB) ratio of 3.21, and the price-to-cash flow ratio of 36.81 may also be considered.
Financial Health
In the three months ended July 30, HealthEquity Inc.’s quick ratio stood at 4.10, while its current ratio was 4.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending July 30 was 0.45, and the total debt-to-equity ratio was 0.45. On the profitability front, the trailing twelve-month gross margin is 59.70% percent. In the year ended July 30, EBITDA margin amounted to 23.08%, whereas operating margins totaled 7.00%. Based on annual data, HQY earned $490.09 million in gross profit and brought in $861.75 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 0.70%. Return on equity (ROE) for the past 12 months was 0.70%.
In HealthEquity Inc.’s quarter-end financial report for July 30, it reported total debt of $873.58 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. HQY’s revenue rose 15.14% to $244.43 million during the quarter, while net income inched up to $242.93 million. While analysts expected HealthEquity Inc. to report $0.48 quarterly earnings, the actual figure was $0.53 per share, beating the consensus estimate by 10.40%. During the quarter, the company generated $63.77 million in EBITDA. The liabilities of HealthEquity Inc. were 1.12 billion at the end of its most recent quarter ended July 30, and its total debt was $935.98 million. The value of shareholders’ equity is $85.63 million.
Technical Picture
This quick technical analysis looks at HealthEquity Inc.’s (HQY) price momentum. With a historical volatility rate of 32.71%, the RSI 9-day stood at 65.10% on 20 September.
With respect to its five-day moving average, the current HealthEquity Inc. price is up by +6.01% percent or $4.12. At present, HQY shares trade +8.36% above its 20-day simple moving average and +36.05% percent above its 100-day simple moving average. However, the stock is currently trading approximately +12.15% above its SMA50 and +10.99% above its SMA200.
Stochastic coefficient K was 85.25% and Stochastic coefficient D was 72.94%, while ATR was 2.43. Given the Stochastic reading of 87.17% for the 14-day period, the RSI (14) reading has been calculated as 61.57%. As of today, the MACD Oscillator reading stands at 1.45, while the 14-day reading stands at 2.06.
Analyst Ratings
Robert W. Baird upgraded its rating on HealthEquity Inc. (NASDAQ: HQY) to an Outperform in a note to investors on Sep-21-23. The analysts firm previously had a Neutral rating on the stock.HealthEquity Inc. (HQY) has been rated Buy by analysts. According to 0 brokerage firms, HQY is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate HealthEquity Inc. stock as buy, with 10 recommending it as overweight.
With a median target price of $85.00, the current consensus forecast for the stock is $72.00 – $94.00. Based on these forecasts, analysts predict HealthEquity Inc. (HQY) will achieve an average price target of $83.67.
